Switching from glucagon-like peptide-1 receptor agonists to tirzepatide in type 2 diabetes: does therapeutic sequencing matter for metabolic dysfunction-associated steatotic liver disease?

Citation record

Journal

Journal of diabetes and its complications

Publication date

2026 Nov

Publication type

Editorial

PMID

42772979

DOI

10.1016/j.jdiacomp.2026.109418

Original source

https://pubmed.ncbi.nlm.nih.gov/42772979/

This page reproduces citation metadata only. Inclusion in the Avion Science research library does not imply endorsement and does not establish the safety, efficacy or intended use of any Avion Science compound. Refer to the original record for complete study information.